Meet Our Featured Speakers

benefits

The European mRNA Conference 2026 presents leading market insights and expert industry sessions on next-generation mRNA therapeutics, innovative formulations, and the latest clinical developments.

Benefits of attending include:

Two days of focused presentations showcasing the latest market insights and addressing key priorities in the pharmaceutical industry through shared results and real-world experiences.
Exclusive networking opportunities to connect with professionals who share similar challenges and experiences in this rapidly evolving sector.
Updates on regional projects and research led by leading vaccination experts and manufacturers, sharing their experiences, findings, and recommendations.
Technical presentations from vaccine developers highlighting the latest results from recent tests and trials, technological advances, and emerging technical expertise.
New case studies presented by leading industry experts showcasing specific examples from global vaccine and treatment development initiatives.
A unique opportunity to connect with a wide range of manufacturers and explore new market opportunities by sharing insights into this evolving industry.

key takeaways

Gain an understanding of the current market dynamics shaping the biotechnology and pharmaceutical industries
Learn how to create effective strategies for vaccine design and development
Hear the latest trends with a comprehensive overview of the year and future projections for the biotechnology and pharmaceutical industries
Discuss innovations and technological advances in vaccine delivery aimed at improving immune responses
Access diverse ideas and perspectives from a wide range of experts and allied industries, incorporating regional insights

who should attend?

This event is intended for leading biotechnology and pharmaceutical companies, government bodies, and policy organisations interested in exploring mRNA-based therapeutics and vaccines for infectious diseases, oncology, and CAR-T cell therapies.

Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, and Managers involved in:

mRNA Experts mRNA Manufacturing Business Development RNA Experts CAR-T Cell Experts Clinical Trials and Approvals Drug Discovery Vaccine Experts Manufacturing Biotherapeutics and Biologics Clinical Diagnostics Research and Development Biotechnology Researchers Companion Diagnostics Strategy and Public Policy Nanotechnologies Theragnostic Sales and Marketing Initiatives Nano and Micro Robotics RNA Medicine Legal and Regulatory Modalities Research Precision Medicine Equipment Certification Services

they've attended our events

Xu Han

Orna Therapeutics

"Inspiring conference with a broad range of insightful, highly relevant topics."

Carolyn Dulney

Roche

"Engaging discussions and outstanding networking experiences."

Mike Zimmer

Novartis

"A valuable experience and a great networking opportunity."

Wensheng Du

GlaxoSmithKline

"It was intuitive session with a fantastic group of people."

Brett Hill

Arcturus Therapeutics

"The event provides strong exposure to industry leaders."

Ying Wang

Johnson & Johnson

"A highly engaging forum offering excellent opportunities to connect with peers."

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.